To Initiate Development Of New Drug Candidate For Fucosidosis
Oct 31 (Reuters) - JCR Pharmaceuticals Co Ltd 4552.T :
* JCR PHARMACEUTICALS CO LTD: TO INITIATE DEVELOPMENT OF
NEW DRUG
CANDIDATE FOR FUCOSIDOSIS
Source text for Eikon: ID:nTSve872dc
Further company coverage: 4552.T
(Reporting by Tokyo Newsroom)
((+81345201189;))
Recent news on JCR Pharmaceuticals
See all newsBrief: JCR Pharmaceuticals Receives Marketing Authorization In Kuwait For Izcargo
Italfarmaco And Jcr Pharmaceuticals Enter Into Exclusive License Agreement For Jr-141 In United States, Europe, And Latin America
Brief: Jcr Pharmaceuticals Receives Orphan Drug Designation For Givinostat In Japan
Brief: Medipal & JCR Dose First Patient In Global Phase I/II Trial OF JR-446 For Mucopolysaccharidosis Type IIIB
Table: Jcr Pharmaceuticals -Q1 group results